Search Results

• • 84 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Low molecular weight heparin in prophylaxis of deep vein thrombosis in Asian general surgical patients: a Kashmir experience

  Authors:Tanveer Dar, Khursheed Wani, Mohd Ashraf, Aijaz Malik, Sanjeed Ahmad, Tariq Gojwari, et al.From:Indian Journal of Critical Care Medicine (Vol. 16, Issue 2) Peer-Reviewed

  April-June 20122,581 words Report 1650LByline: Tanveer. Dar, Khursheed. Wani, Mohd. Ashraf, Aijaz. Malik, Sanjeed. Ahmad, Tariq. Gojwari, Arshad. Iqbal Background and Objectives: Deep vein thrombosis (DVT) occurs at a lower rate in Asia than in the rest...

• Graduated compression stockings to prevent deep vein thrombosis

  Authors:L. Walker and S. LamontFrom:Nursing Standard (Vol. 22, Issue 40) Peer-Reviewed

  June 11, 20082,906 words Article 1580LSummary This article describes the correct use and length of graduated elastic compression stockings to prevent deep vein thrombosis (DVT) in general surgical patients. The authors aim to establish whether above or...

• Low molecular weight heparin in treating patients with lung cancer received chemotherapy: A meta-analysis

  Authors:Zi-Li Liu, Qian Wang, Ming Wang, Bin Wang, and Li-Nian HuangFrom:Journal of Cancer Research and Therapeutics (Vol. 14, Issue 9) Peer-Reviewed

  June 20183,346 words Report 1510LByline: Zi-Li. Liu, Qian. Wang, Ming. Wang, Bin. Wang, Li-Nian. Huang Objective: To systematically review the efficacy and safety of low molecular weight heparin (LMWH) in treating patients with lung cancer received...

• How to use low-molecular-weight heparin to prevent DVT: low-molecular-weight heparin, a major advance in the treatment of deep vein thrombosis, is also a vastly underused means of preventing this disorder. Here are recommendations on how and when to use this medication

  Authors:Samuel Z. Goldhaber, Simon J. McRae, and Jenny WangFrom:Patient Care (Vol. 39, Issue 4) Peer-Reviewed

  Apr. 20053,644 words Article This year, more than 1 in 1000 Americans will develop acute deep vein thrombosis (DVT) or pulmonary embolism (PE), known collectively as venous thromboembolism (VTE). The death rate from PE is surprisingly high. (1) A...

• Thromboprophylaxis with the low-molecular-weight heparin bemiparin sodium in elderly medical patients in usual clinical practice: the ANCIANOS study

  Authors:Leocadio Rodriguez-Manas, Ricardo Gomez-Huelgas, Fernando Veiga-Fernandez, Gema Monteagudo Ruiz, and Javier Martinez GonzalezFrom:Clinical Drug Investigation (Vol. 30, Issue 5) Peer-Reviewed

  May 20104,326 words Clinical report Background: Venous thromboembolism (VTE) is a preventable common disease in geriatric medical patients, causing substantial morbidity and mortality. Objective: To assess the effectiveness and safety of bemiparin...

• Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications

  Authors:Anna Surbone, Luca Fuso, Roberto Passera, Annamaria Ferrero, Cristiana Marchese, Cosimo Martino, et al.From:BMC Research Notes (Vol. 5, Issue 1) Peer-Reviewed

  Sept. 23, 20125,038 words Article 1510LBackground Hepatocyte Growth Factor (HGF) enhances cytotoxicity of paclitaxel (PTX) and cisplatin (CDDP) in human ovarian cancer cells. Because of potential pitfalls of HGF exogenous administration, we investigated...

• GlycCompSoft: Software for Automated Comparison of Low Molecular Weight Heparins Using Top-Down LC/MS Data

  Authors:Xiaohua Wang, Xinyue Liu, Lingyun Li, Fuming Zhang, Min Hu, Fuji Ren, et al.From:PLoS ONE (Vol. 11, Issue 12) Peer-Reviewed

  Dec. 12, 20164,383 words Report 1540LLow molecular weight heparins are complex polycomponent drugs that have recently become amenable to top-down analysis using liquid chromatography-mass spectrometry. Even using open source deconvolution software,...

• Low molecular weight heparins/ warfarin: fatal tumour-associated haemorrhage in an elderly patient: case report

  From:Reactions Weekly (Issue 1312)

  July 31, 2010261 words Brief article 1020LA 69-year-old man developed tumour-associated haemorrhage during anticoagulation including low molecular weight heparin [specific drug not stated] and warfarin [routes, dosages and durations of therapies to reaction...

• Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy *

  Authors:Alex C. Spyropoulos, Floyd J. Frost, Judith S. Hurley, and Melissa RobertsFrom:Chest (Vol. 125, Issue 5) Peer-Reviewed

  May 20046,063 words Article Study objectives: There have been no health-care cost evaluations comparing the use of low-molecular-weight heparin (LMWH) to unfractionated heparin (UH) as "bridge therapy" in the perioperative period in patients...

• Low molecular weight heparin to treat pulmonary embolism

  Author:Iqbal MalikFrom:Heart (Vol. 90, Issue 4) Peer-Reviewed

  Apr. 2004198 words Brief article Low molecular weight heparin to treat pulmonary embolism * In a meta-analysis of 12 trials, low molecular weight heparin was associated with a non-significant decrease in recurrent symptomatic venous thromboembolism at...

• Effect of prophylactic treatment with low-molecular-weight heparin bemiparin sodium on serum potassium levels: a prospective observational study

  Authors:Olga H. Torres, Nerea Hernandez, Esther Francia, Montserrat Barcelo, Jose Mateo, and Domingo RuizFrom:Drugs & Aging (Vol. 27, Issue 5) Peer-Reviewed

  May 20103,732 words Clinical report Background: Hyperkalaemia is a serious adverse effect of unfractionated heparin, but the effect of low-molecular-weight heparins (LMWHs) on potassium levels is not clear. Previous studies have shown a disparity of...

• The identity problem: the US Food and Drug Administration (FDA) decision to approve a generic heparin derivative without clinical safety or efficacy data raises the possibility that clinical trials might not always be required for the approval of follow-on biologics

  From:Nature Biotechnology (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 2010925 words Editorial 1460LAt the end of July, the FDA granted marketing approval to an anticoagulant, the low-molecular-weight heparin (LMWH) enoxaparin sodium injection. The product, co-developed by Momenta Pharmaceuticals and Sandoz, was...

• Can low-molecular-weight heparin improve the outcome of patients with operable non-small cell lung cancer? An urgent call for research

  Authors:Marco Alifano, Giovanni Benedetti, and Rocco TrisoliniFrom:Chest (Vol. 126, Issue 2) Peer-Reviewed

  Aug. 20045,085 words Article Key words: low-molecular weight heparin; lung cancer; outcome; recurrence; surgery Abbreviations: LMWH = low-molecular-weight heparin; NSCLC non-small cell lung cancer; UH = unfractioned heparin; VTE = venous...

• Management of intentional overdose of low-molecular-weight heparin.

  Authors:Clara Lu, Mark A. Crowther, and Siraj MithoowaniFrom:CMAJ: Canadian Medical Association Journal (Vol. 194, Issue 4) Peer-Reviewed

  Jan. 31, 20222,141 words Clinical report 1670LA 42-year-old man presented to the emergency department 2 hours after self-injecting 225 000 units of dalteparin (15 prefilled 15000-unit vials) with intent to self-harm. The patient's medical history included...

• Plasma anti-Xa monitoring for low-molecular-weight heparins in patients with chronic kidney disease

  Authors:Maurizio Gallieni, Alma Martini, Antonio Granata, and Maria FusaroFrom:Clinical Pharmacokinetics (Vol. 49, Issue 11) Peer-Reviewed

  Nov. 2010971 words Letter to the editor 2870LWe read with great interest the article by Al Sallami et al., [1] indicating that routine plasma anti-Xa monitoring is required for better management of patients treated with low-molecular-weight heparins (LMWHs). We...

• Heparin: cervical epidural haematoma in an elderly patient: case report

  From:Reactions Weekly (Issue 1317)

  Sept. 4, 2010382 words Brief article, Case ... 1070L[S] A 65-year-old man developed an acute spontaneous cervical epidural haematoma during treatment with low molecular-weight heparin [LMWH; route of administration not stated]. The man was diagnosed with acute...

• Nadroparin calcium: type II heparin-induced thrombocytopenia in an elderly patient: case report

  From:Reactions Weekly

  Sept. 19, 2009274 words Brief article, Case ... [S] A 65-year-old man developed type II heparin-induced thrombocytopenia after receiving thrombosis prophylaxis with nadroparin calcium. The man underwent uncemented total hip replacement; subsequently, he...

• Low molecular weight heparins: elevated free thyroxine levels in a premature neonate?: case report

  From:Reactions Weekly (Issue 1235)

  Jan. 17, 2009178 words Brief article, Case ... 1170LA male neonate born at 35 weeks' gestation was treated with a low molecular weight heparin [dosage not stated] for a blood clot, from day 3 to day 14 of life. On day 4 of life, the boy recorded a free thyroxine (FT4)...

• Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination

  Authors:Henning Hagmann, Verena Bossung, Abdel Ali Belaidi, Alexander Fridman, S. Ananth Karumanchi, Ravi Thadhani, et al.From:PLoS ONE (Vol. 9, Issue 1) Peer-Reviewed

  Jan. 21, 20145,985 words Article 1520LAuthor(s): Henning Hagmann 1,*, Verena Bossung 2, Abdel Ali Belaidi 3, Alexander Fridman 2, S. Ananth Karumanchi 4, Ravi Thadhani 5, Bernhard Schermer 1, Peter Mallmann 2, Guenter Schwarz 3, Thomas Benzing 1, Paul T....

• Application of microbial alkaloid prodigiosin as a potent matrix for the MALDI mass spectrometry analysis of low-molecular-weight plant antioxidants

  Authors:A.B. Duzhak, T.D. Williams, Z.I. Panfilova, Yu.P. Tsentalovich, and T.G. DuzhakFrom:Journal of Analytical Chemistry (Vol. 71, Issue 13) Peer-Reviewed

  Dec. 15, 20165,458 words Report 1480LMicrobial alkaloid prodigiosin is proposed as a new effective matrix for the analysis of low-molecular-weight plant antioxidants by MALDI mass spectrometry in the negative ion detection mode. It is demonstrated that the...